<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">1.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Tuberculosis</HT>
</TXT>
</NP>
</TI>
The single intradermal tuberculin test using bovine tuberculin shall be carried out according to Annex B to Directive 64/432/EEC
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">2.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Brucellosis</HT>
</TXT>
</NP>
</TI>
-
(i)
The serum agglutination test complement fixation test and buffered brucella antigen test: carried out according to paragraphs A, B and D of Annex C to Directive 64/432/EEC.
-
(ii)
The enzyme linked immuno-absorbent assays tests (ELISA) carried out in accordance with the provisions set up in the Annex to Decision 2000/330/EC
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">3.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Enzootic bovine leukosis</HT>
</TXT>
</NP>
</TI>
The agar gel immuno-diffusion test and the enzyme linked immuno-absorbent assay test (ELISA): carried out according to paragraphs A and C, chapter II of Annex D to Council Directive 64/432/EEC.
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">4.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Bluetongue</HT>
</TXT>
</NP>
</TI>
The blocking or competitive Elisa test: carried out according to paragraph 4.A, Chapter I, Annex I to Commission Decision 91/189/EEC
The agar gel immuno-diffusion test shall be carried out according to paragraph 4.B, Chapter I, Annex I to Decision 91/189/EEC
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">5</HT>.</NO.P>
<TXT>
<HT TYPE="BOLD">Epizootic haemorrhagic disease</HT>
</TXT>
</NP>
</TI>
The agar gel immuno-diffusion test: carried out according to paragraph 5, Chapter I, Annex I to Decision 91/189/EEC
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">6.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Infectious bovine rhino-tracheitis/infectious pustular vulvo-vaginitis</HT>
</TXT>
</NP>
</TI>
-
(i)
the serum neutralisation test carried out according to Annex I, Chapter I, paragraph 7 to Decision 91/198/EEC.
-
(ii)
Any other test recognised in the frame of Commission Decision 93/42/EEC of 21 December 1992 concerning additional guarantees relating to infectious bovine rhino-tracheitis for bovines destined for Member States or Regions of Member States free from the disease
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">7.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Foot-and-mouth disease (FMD)</HT>
</TXT>
</NP>
</TI>
-
(i)
Collecting oesophageal/pharyngeal samples and testing: carried out according to paragraph 10.A, Chapter I, Annex I to Decision 91/189/EEC
-
(ii)
The virus neutralisation test: carried out according to paragraph 10.B, Chapter I, Annex I to Decision 91/189/EEC
-
(iii)
The detection and quantification of antibody by ELISA
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">8.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Aujeszky's disease</HT>
</TXT>
</NP>
</TI>
-
(i)
The serum neutralisation test
-
(ii)
Any other test recognised in the frame of Commission Decision 93/244/EEC of 2 April 1993 concerning additional guarantees relating to Aujeszky's disease for pigs destined for certain parts of the territory of the Community
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">9.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Swine vesicular disease</HT>
</TXT>
</NP>
</TI>
The serum neutralisation test: carried out according to paragraph 7, Chapter II, Annex I to Decision 91/189/EEC
<TI>
<NP>
<NO.P>
<HT TYPE="BOLD">10.</HT>
</NO.P>
<TXT>
<HT TYPE="BOLD">Classical swine fever</HT>
</TXT>
</NP>
</TI>
Tests for classical swine fever shall be carried out according to Annex I to Council Directive 80/217/EEC.